See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Tariffs
Trade War
Baseball
Donald Trump
Stock Markets
Social Media
Artificial Intelligence
Trade
Natural Disasters
Arsenal FC
European Union
Taxes
Published • loading... • Updated

Kelso Pharma secures £140m of acquisition funding and appoints senior pharma executive as Non-Executive Director - Scottish Business News

Summary by Scottish Business News
Kelso Pharma, the growing specialty pharma business backed by Apposite Capital, the healthcare specialist private equity investor, announces that it has secured over £140 million of acquisition funding and appointed former ADVANZ PHARMA CEO, Graeme Duncan, as Non-Executive Director. A proportion of the funding was used by Kelso Pharma in its acquisition of ALTURiX last month. The remaining facilities will be used to facilitate further acquisitio…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

2 Articles

All
Left
Center
Right
Scottish Business NewsScottish Business News

Kelso Pharma secures £140m of acquisition funding and appoints senior pharma executive as Non-Executive Director - Scottish Business News

Kelso Pharma, the growing specialty pharma business backed by Apposite Capital, the healthcare specialist private equity investor, announces that it has secured over £140 million of acquisition funding and appointed former ADVANZ PHARMA CEO, Graeme Duncan, as Non-Executive Director. A proportion of the funding was used by Kelso Pharma in its acquisition of ALTURiX last month. The remaining facilities will be used to facilitate further acquisitio…

Read Full Article
Spreng ThomsonSpreng Thomson

Kelso Pharma secures £140m of acquisition funding and appoints senior pharma executive as Non-Executive Director - Spreng Thomson

Kelso Pharma, the growing specialty pharma business backed by Apposite Capital, the healthcare specialist private equity investor, announces that it has secured over £140 million of acquisition funding and appointed former ADVANZ PHARMA CEO, Graeme Duncan, as Non-Executive Director. The post Kelso Pharma secures £140m of acquisition funding and appoints senior pharma executive as Non-Executive Director appeared first on Spreng Thomson.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Spreng Thomson broke the news in on Thursday, March 27, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Kelso, Scotland

Kelso, Scotland

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

News
For You
SearchBlindspotLocal